Analysts Lower Ultragenyx (RARE) Target but Stay Bullish

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On January 6, H.C. Wainwright reduced its price target on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) from $80 to $60 but kept its Buy rating on the stock. The reduced price target still represents a significant upside from the current price. This update comes after the company announced that its two pivotal trials for setrusumab in osteogenesis imperfecta (OI), Cosmic and Orbit, ...